Crispr Therapeutics Ag (CRSP)

03:36 AM

CRISPR Therapeutics (NASDAQ:CRSP) Trading 8.2% HigherWhat's Next? - MarketBeat

03:36 AM

01:33 AM

Crispr Therapeutics stock hits 52-week high at 71.14 USD By Investing.com - Investing.com Australia

01:33 AM

07:00 AM

From 160 Licenses to $1B Raised: Australia's Largest University Opens Boston Hub to Accelerate Biotech Innovation - Stock Titan

07:00 AM

01:49 AM

BMO Reaffirms Outperform on CRISPR Therapeutics (CRSP) After Sirius Collaboration - MSN

01:49 AM

Oct 01, 2025

Combining price and volume data for CRISPR Therapeutics AG2025 Top Gainers & Reliable Price Breakout Alerts - newser.com

Oct 01, 2025

Oct 01, 2025

CRISPR Therapeutics AG stock outlook for YEARJuly 2025 Levels & Weekly High Conviction Ideas - newser.com

Oct 01, 2025

Oct 01, 2025

Crispr Therapeutics to present preclinical data on AATD at ESGCT 2025 - TipRanks

Oct 01, 2025

Oct 01, 2025

Signal strength of CRISPR Therapeutics AG stock in tech scanners2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com

Oct 01, 2025

Oct 01, 2025

CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress - The Manila Times

Oct 01, 2025

Oct 01, 2025

CRISPR Therapeutics to Present Novel SyNTase Gene Editing Technology at ESGCT 2025 Annual Congress - Quiver Quantitative

Oct 01, 2025

Oct 01, 2025

Leading vs lagging indicators on CRISPR Therapeutics AG performance2025 EndofYear Setup & Growth Focused Stock Reports - newser.com

Oct 01, 2025

Oct 01, 2025

CRISPR Therapeutics to Present Preclinical Data on Alpha-1 - GlobeNewswire

Oct 01, 2025

Oct 01, 2025

What valuation ratios show for CRISPR Therapeutics AG (1CG) stockEarnings Miss & High Return Trade Opportunity Guides - newser.com

Oct 01, 2025

Oct 01, 2025

CRISPR's SyNTase Gene Editor Shows 95% Efficacy in AATD Models | CRSP Stock News - Stock Titan

Oct 01, 2025

Oct 01, 2025

Got $200? 2 Healthcare Stocks to Buy and Hold Forever - The Motley Fool

Oct 01, 2025

Oct 01, 2025

H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics AG (CRSP) Stock - Yahoo Finance

Oct 01, 2025

Oct 01, 2025

U.S. Gene Editing Market Projections 2025-2032: Key Trends, - openPR.com

Oct 01, 2025

Sep 30, 2025

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts - MSN

Sep 30, 2025

Sep 30, 2025

H.C. Wainwright Reaffirms Buy Rating on CRISPR Therapeutics After CTX310 Update - msn.com

Sep 30, 2025

Sep 30, 2025

Could This Beaten-Down Stock Help You Become a Millionaire? - AOL.com

Sep 30, 2025

Sep 30, 2025

Relative strength of CRISPR Therapeutics AG in sector analysisTrade Risk Summary & Fast Moving Stock Watchlists - newser.com

Sep 30, 2025

Sep 30, 2025

What analysts say about CRISPR Therapeutics AG stockVWAP Trading Strategies & Exceptional Return Opportunities - earlytimes.in

Sep 30, 2025

Sep 30, 2025

Does CRISPR Therapeutics AG qualify in momentum factor screeningPortfolio Profit Report & Stock Market Timing Techniques - newser.com

Sep 30, 2025

Sep 29, 2025

Order flow analysis tools used on CRISPR Therapeutics AG2025 Retail Activity & Fast Gain Swing Trade Alerts - newser.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 09:36:12 - newser.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 07:23:14 - newser.com

Sep 29, 2025

Sep 29, 2025

Measuring CRISPR Therapeutics AG’s beta against major indices2025 Major Catalysts & High Yield Equity Trading Tips - newser.com

Sep 29, 2025

Sep 29, 2025

Will a bounce in CRISPR Therapeutics AG offer an exit2025 Market Overview & Risk Managed Investment Entry Signals - newser.com

Sep 29, 2025

Sep 29, 2025

What candlestick patterns are forming on CRISPR Therapeutics AGJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 03:07:00 - newser.com

Sep 29, 2025

Sep 29, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 01:02:34 - newser.com

Sep 29, 2025

Sep 28, 2025

What drives CRISPR Therapeutics AG stock priceDividend Reinvestment Plans & Big Data Market Reports - earlytimes.in

Sep 28, 2025

Sep 28, 2025

Is CRISPR Therapeutics AG a good long term investmentSupport and Resistance Levels & Access Free Risk Analysis Before You Invest - earlytimes.in

Sep 28, 2025

Sep 27, 2025

Published on: 2025-09-27 21:01:29 - newser.com

Sep 27, 2025

Sep 27, 2025

Is the First Phase 2 Dosing of SRSD107 Shifting CRISPR Therapeutics’ (CRSP) Investment Landscape? - Sahm

Sep 27, 2025

Sep 27, 2025

Voya Investment Management LLC Boosts Stock Position in CRISPR Therapeutics AG $CRSP - MarketBeat

Sep 27, 2025

Sep 26, 2025

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why - sharewise.com

Sep 26, 2025

Sep 26, 2025

CRISPR Therapeutics AG Stock Analysis and ForecastOptions Trading Strategies & Low Risk Investment Trading - Early Times

Sep 26, 2025

Sep 26, 2025

Wealth Enhancement Advisory Services LLC Decreases Stock Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat

Sep 26, 2025

Sep 24, 2025

Exchange Traded Concepts LLC Acquires New Shares in CRISPR Therapeutics AG $CRSP - MarketBeat

Sep 24, 2025

Sep 23, 2025

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know - sharewise.com

Sep 23, 2025

Sep 23, 2025

Bouvel Investment Partners LLC Acquires 9,458 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat

Sep 23, 2025

Sep 23, 2025

BMO Capital reiterates Outperform on CRISPR Therapeutics stock, sees potential in thrombosis market - Investing.com Nigeria

Sep 23, 2025

Sep 23, 2025

Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? - sharewise.com

Sep 23, 2025

Sep 23, 2025

CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU - Yahoo Finance

Sep 23, 2025